As this review clearly focusses on the importance of Ca2+ handling proteins in the development of hypertrophy and heart failure in DCM, we summarize here some of the novel therapeutic approaches targeting Ca2+ handling proteins in modulating this aberrant expression and activity to improve symptoms in patients with DCM. Here, CA2 is linked to familial dilated cardiomyopathy.